SAMIVIP Trademark

Trademark Overview


On Thursday, May 6, 2021, a trademark application was filed for SAMIVIP with the United States Patent and Trademark Office. The USPTO has given the SAMIVIP trademark a serial number of 90693307. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 15, 2023. This trademark is owned by NeuroRx, Inc.. The SAMIVIP trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention of coronavirus infections; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of coronavirus infections; Pharmaceutical preparations, namely, antivirals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
samivip

General Information


Serial Number90693307
Word MarkSAMIVIP
Filing DateThursday, May 6, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 15, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 15, 2022

Trademark Statements


Goods and ServicesPharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for the prevention of coronavirus infections; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for the treatment of viral infections; Pharmaceutical preparations for the treatment of coronavirus infections; Pharmaceutical preparations, namely, antivirals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders
Pseudo MarkSAMI VIP

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, August 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNeuroRx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWilmington, DE 19801

Party NameNeuroRx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWilmington, DE 19801

Trademark Events


Event DateEvent Description
Monday, May 15, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, May 15, 2023ABANDONMENT - NO USE STATEMENT FILED
Friday, October 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 5, 2022SOU EXTENSION 1 GRANTED
Wednesday, October 5, 2022SOU EXTENSION 1 FILED
Wednesday, October 5, 2022TEAS EXTENSION RECEIVED
Monday, August 22, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, April 15, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, April 15, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 15, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 12, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 15, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 15, 2022PUBLISHED FOR OPPOSITION
Wednesday, January 26, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 13, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, January 11, 2022ASSIGNED TO EXAMINER
Saturday, August 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, May 10, 2021NEW APPLICATION ENTERED